Connect with us
European Gaming Congress 2024

Fintech PR

Bitget Wallet Attends Devconnect Istanbul & Holds Exclusive Collaboration Event with 1inch

Published

on

bitget-wallet-attends-devconnect-istanbul-&-holds-exclusive-collaboration-event-with-1inch

VICTORIA, Seychelles, Nov. 14, 2023 /PRNewswire/ — Bitget Wallet, renowned as a premier one-stop Web3 trading wallet and formerly known as BitKeep Wallet, makes a significant appearance at Devconnect 2023 in Istanbul, Turkey. This week-long Ethereum developer conference is a crucial gathering for Ethereum’s developers, researchers, and key figures to discuss technical advancements and challenges. Along with its attendance at the conference, Bitget Wallet sponsors the unStable Summit, a global summit focusing on stablecoins, on November 15. This event sees Bitget Wallet joining forces with industry giants like Curve Finance. In a similar vein, the wallet is collaborating with 1inch, a prominent player in the Web3 space, to hold an exclusive offline event.

Exploring Optimal Swap Experiences: Bitget Wallet and 1inch Collaboration

The strong alliance between Bitget Wallet and 1inch marks a significant stride in the decentralized exchange (DEX) arena. Renowned for its DEX aggregation and efficient trading algorithms, 1inch ensures users receive the best transaction prices and minimal slippage. Bitget Wallet, focusing on decentralized trading as a cornerstone of its services, aims to revolutionize the Web3 transaction experience and emerge as the ultimate decentralized trading gateway.

The depth of this partnership is showcased through the incorporation of 1inch into Bitget Wallet’s Swap feature, Bitget Swap. Bitget Swap, playing a pivotal role in the wallet, now supports nearly 30 mainnets. It merges the liquidity of various DEXs and cross-chain bridges, with 1inch being a key player. The integration includes the 1inch Limit Order Protocol, empowering users to place orders at specific prices on multiple chains.

Bitget Swap is at the forefront of product innovation, introducing features such as gas-free transactions and automatic slippage adjustments, significantly enhancing the user experience. Notably, it has pioneered the industry-first feature of on-chain candlestick charts, providing users with real-time, insightful data for informed trading decisions. All these features streamline the trading process while reducing user costs and offering a seamless multi-chain trading experience.

Advertisement
Stake.com

Further, the inclusion of Flashbots in Bitget Swap enhances transaction privacy and security, safeguarding against malicious MEV attacks on the Ethereum chain. This feature also ensures users benefit from any MEV proceeds generated during transactions.

Bitget Swap’s versatility extends to various trading modes, including limit orders and the globally accessible Quick Buy service. These features bring the convenience and familiarity of centralized trading platforms to the decentralized wallet environment.

Upcoming Turkish Ecosystem Expansion Plan

Announced at Devconnect Istanbul, Bitget Wallet’s Turkish ecosystem expansion plan addresses Turkey’s increasing interest in cryptocurrencies, especially as a hedge against high inflation. The diversification of the market and growing interest in emerging concepts like NFTs and the Metaverse bode well for Web3 development in the region.

Bitget Wallet is highly optimistic about Turkey’s potential in the Web3 domain. Seizing this event as a pivotal opportunity, the team plans to engage with local Turkish projects, key opinion leaders (KOLs), and communities. This initiative is aimed at driving a range of ecological activities specifically for the Turkish market, to deliver unparalleled products and services to Turkish users in the Web3 space.

Advertisement
Stake.com

Innovative Leadership in the Trading Wallet Domain

As a leading Web3 trading wallet, Bitget Wallet offers a comprehensive array of on-chain products and DeFi services, including wallet functionality, swap, NFT trading, DApp browsers, and more. The recent introduction of the MPC wallet highlights its commitment to security and usability in Web3.

Bitget Wallet has set new industry standards with several pioneering achievements:

The first to offer an overview of the entire blockchain ecosystem, integrating assets across multiple blockchains.

The first to introduce a DEX market feature, utilizing real-time blockchain data for intelligent asset management and trend analysis.

Advertisement
Stake.com

The first to enable seamless cross-chain transactions, simplifying the transfer of assets between public chains without the need for understanding complex processes like gas fees and cross-chain bridges.

The first to support a comprehensive NFT marketplace, fully integrating the Web3 ecosystem within its wallet services.

The user base and recognition of Bitget Wallet are consistently growing. It now boasts over 12 million global users, ranking as the seventh most popular crypto hot wallet globally according to CoinGecko. Additionally, data.ai ranks it the fourth most downloaded wallet worldwide in the past month.

According to DappRadar, Bitget Swap often features in the top ten of all DeFi projects in terms of transaction volume and active users. It competes closely with trending projects like MetaMask and is sometimes even ahead. The community particularly favors the Swap function for its smooth and efficient trading experience.

Photo – https://mma.prnewswire.com/media/2276158/Bitget_Wallet_top_4_installed_wallet_Oct_2023_on_iOS_Google.jpg

Advertisement
Stake.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/bitget-wallet-attends-devconnect-istanbul–holds-exclusive-collaboration-event-with-1inch-301987475.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

Advertisement
Stake.com

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

Advertisement
Stake.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

Advertisement
Stake.com

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

Advertisement
Stake.com

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Advertisement
Stake.com
Continue Reading

Trending